cbdMD Signs Exclusive Agreement to Enter Israeli Market with IM Cannabis Corp.
Cannabis Law Report
AUGUST 9, 2021
With this agreement, , we will have the opportunity to shape the Israeli CBD market and leverage IMC’s new and expanding retail presence, distribution capabilities and data-driven insights to reach our patients and future consumers with a leading brand such as cbdMD,” said Oren Shuster, IMC’s CEO. IMC also operates MYM Nutraceuticals Inc.
Let's personalize your content